Unknown

Dataset Information

0

Clinical and Genomic Characteristics of Adult Diffuse Midline Glioma.


ABSTRACT:

Purpose

The treatment outcomes and genomic profiles of diffuse midline glioma (DMG) in adult patients are rarely characterized. We performed a retrospective study to evaluate the clinicogenomic profiles of adult patients with brain DMG.

Materials and methods

Patients aged ≥ 18 years diagnosed with brain DMG at Seoul National University Hospital were included. The clinicopathological parameters, treatment outcomes, survival, and genomic profiles using 82-gene targeted next-generation sequencing (NGS) were analyzed. The 6-month progression-free survival (PFS6) after radiotherapy and overall survival (OS) were evaluated.

Results

Thirty-three patients with H3-mutant brain DMG were identified. The median OS from diagnosis was 21.8 months (95% confidence interval [CI], 13.2 to not available [NA]) and involvement of the ponto-medullary area tended to have poor OS (median OS, 20.4 months [95% CI, 9.3 to NA] vs. 43.6 months [95% CI, 18.2 to NA]; p=0.07). Twenty-four patients (72.7%) received radiotherapy with or without temozolomide. The PFS6 rate was 83.3% (n=20). Patients without progression at 6 months showed significantly prolonged OS compared with those with progression at 6 months (median OS, 24.9 months [95% CI, 20.4 to NA] vs. 10.8 months [95% CI, 4.0 to NA]; p=0.02, respectively). Targeted NGS was performed in 13 patients with DMG, among whom nine (69.2%) harbored concurrent TP53 mutation. Two patients (DMG14 and DMG23) with PIK3CAR38S+E545K and KRASG12A mutations received matched therapies. Patient DMG14 received sirolimus with a PFS of 8.4 months.

Conclusion

PFS6 after radiotherapy was associated with prolonged survival in adult patients with DMG. Genome-based matched therapy may be an encouraging approach for progressive adult patients with DMG.

SUBMITTER: Park C 

PROVIDER: S-EPMC8053865 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical and Genomic Characteristics of Adult Diffuse Midline Glioma.

Park Changhee C   Kim Tae Min TM   Bae Jeong Mo JM   Yun Hongseok H   Kim Jin Wook JW   Choi Seung Hong SH   Lee Soon-Tae ST   Lee Joo Ho JH   Park Sung-Hye SH   Park Chul-Kee CK  

Cancer research and treatment 20201109 2


<h4>Purpose</h4>The treatment outcomes and genomic profiles of diffuse midline glioma (DMG) in adult patients are rarely characterized. We performed a retrospective study to evaluate the clinicogenomic profiles of adult patients with brain DMG.<h4>Materials and methods</h4>Patients aged ≥ 18 years diagnosed with brain DMG at Seoul National University Hospital were included. The clinicopathological parameters, treatment outcomes, survival, and genomic profiles using 82-gene targeted next-generati  ...[more]

Similar Datasets

| S-EPMC7748263 | biostudies-literature
| S-EPMC9052283 | biostudies-literature
| S-EPMC7846091 | biostudies-literature
| S-EPMC10711257 | biostudies-literature
| S-EPMC8694136 | biostudies-literature
| S-EPMC11443003 | biostudies-literature
| S-EPMC8894220 | biostudies-literature
| S-EPMC9676429 | biostudies-literature
| S-EPMC10263181 | biostudies-literature
| S-EPMC7962140 | biostudies-literature